The Case for Expensive Antibiotics

  • Af
  • Episode
      749
  • Published
      21. sep. 2018
  • Forlag
0 Anmeldelser
0
Episode
749 of 2526
Længde
7M
Sprog
Engelsk
Format
Kategori
Fakta

A handful of years ago, a small pharmaceutical company quietly acquired the rights to an old but commonly used antibiotic. Few noticed until last week, when the new owner did something that’s recently become common in the world of pharmaceuticals: It abruptly raised the price. A lot. The manufacturer is called Nostrum Laboratories, and the drug for which it hiked the price—by more than 400 percent—is called nitrofurantoin.

Learn about your ad choices: dovetail.prx.org/ad-choices


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...